Bullish CEO Interviews29 Jan 2026 11:40
As well as Hvivo’s continued robust diversification and “no longer a one trick pony” (albeit a world leader at it), other CEO statements were most revealing.
https://www.youtube.com/watch?v=08A3lnn8iF8
From the Proactive Investors interview:
“We've also built a couple of preferred providerships, at CRS especially, where we’re getting repeat business from our clients. We have some of the larger opportunities, such as ILiAD, still on the books, and we look forward to building some of those and moving some of the pipeline into contracts.
And I think that's one of the key differences that we've seen more movement in the conversion of opportunities into contracts. And that's something we'll look see progress further in EARLY 2026!!!”
https://www.youtube.com/watch?v=xXKfsKrWlSA
From the VOX MARKETS interview:
“Oh yeah, there's number of large opportunities especially in the human challenge trials that we are looking to convert in 2026 that we are very positive about.
Also a number of Phase 1, Phase 2 opportunities are looking strong on top of the lab, and the consulting arm is also doing well. So having a variety of portfolio of services means that we're able to diversify across different groups within the company and convert that sales pipeline into revenue.”
Think once the traders have had their pound of flesh early doors, the share price should gather momentum as an unmistakable growth stock opportunity.
No doubt he’ll elucidate further at this evening’s live presentation, perhaps even why just last month he saw fit to buy £200,000 worth at today's share price no less (after all his insight will always be superior to ours i.e. follow the money!).
Technical charts look poised too, so all to play for.
Sign In
Follow the stocks
